
EU pharma chief calls for European Nasdaq to boost biotech innovation
Published on 02/07/2025 - 14:47 GMT+2 Stefan Oelrich, president of Bayer’s pharmaceutical division and newly appointed head of the EU’s pharmaceutical lobby EFPIA, pointed out the urgent need for capital market reform to support biotech development …